Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Noonan Syndrome × Lamotrigine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 2 Pain 1 Noonan Syndrome 1 Neurotoxicity Syndromes 1 Cognition Disorders 1

Interventions

osimertinib 2 sotorasib 1 nazartinib 1 cobimetinib 1 Waiting Lists 1 Lovastatin 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡